1V-LSD
| Clinical data | |
|---|---|
| Other names | 1-Valeryl-LSD; 1-Valeroyl-LSD; 1-Pentanoyl-LSD; Valerie; 1-Valeryl-N,N-diethyllysergamide |
| Routes of administration | Oral |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Duration of action | 6–8 hours (reportedly) |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C25H33N3O2 |
| Molar mass | 407.558 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
1V-LSD, also known as 1-valeryl-LSD or by the nickname Valerie, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is an analogue of LSD and is thought to act as a prodrug of LSD. The drug has been encountered as a novel designer recreational drug.